News & Updates

The Austral Dx team will attend EUSEM 2026, the European Congress for Emergency Medicine organized each year by the European Society for Emergency Medicine.

AUSTRAL Dx franchit une étape clé de son développement avec l’obtention, le 17 avril 2026, de la certification ISO 13485.

When a pulmonologist interprets a respiratory oscillometry test, the technique provides a measurement of global pulmonary mechanics but cannot localize regional mechanical abnormalities.

Austral Dx joins France Deeptech, the association bringing together nearly 300 key players across the French deeptech ecosystem.

Austral Dx will present its breakthrough technology at the HealthTech Investor Summit in Utrecht, a leading European event connecting healthtech startups with investors.

Par BpiFrance dans le cadre de France 20230.

Heart and lung health: promising preliminary results from the study to non-invasively diagnose lung and heart pathology, conducted by...

On Thursday, 24 July 2025, AUSTRAL Dx announced the completion of a €2.5 million seed round led by Sorbonne Venture by Audacia and Aloe Private Equity, with participation from iXcore, Kima Ventures, Better Angle, Super Capital, Capital Cell, Paris Business Angels, Angels Santé, several individual business angels, as well as the support of Bpifrance / France 2030 via the i-Nov competition.

AUSTRAL Dx franchit une étape clé de son développement avec l’obtention, le 17 avril 2026, de la certification ISO 13485.

Austral Dx joins France Deeptech, the association bringing together nearly 300 key players across the French deeptech ecosystem.

Austral Dx will present its breakthrough technology at the HealthTech Investor Summit in Utrecht, a leading European event connecting healthtech startups with investors.

Par BpiFrance dans le cadre de France 20230.

Heart and lung health: promising preliminary results from the study to non-invasively diagnose lung and heart pathology, conducted by...

On Thursday, 24 July 2025, AUSTRAL Dx announced the completion of a €2.5 million seed round led by Sorbonne Venture by Audacia and Aloe Private Equity, with participation from iXcore, Kima Ventures, Better Angle, Super Capital, Capital Cell, Paris Business Angels, Angels Santé, several individual business angels, as well as the support of Bpifrance / France 2030 via the i-Nov competition.